Skip to main content

Immunology

We are advancing innovative science and transformative medicines for people living with inflammatory and autoimmune diseases, including a portfolio of first in class programs and innovative development approaches across inflammatory bowel disease (IBD), respiratory, and rheumatological diseases.

Partnering opportunities we are looking for:

  • Gastroenterology, Respiratory, Nephrology

  • Innate, Adaptive, Fibrosis, Tolerance and Tissue Regeneration Targets

Example partnerships

  • Telavant

    Acquisition to further develop and commercialise RVT-3101, a Phase-3 ready antibody with first-in-class and best-in-disease potential to treat patients suffering from IBD including ulcerative colitis (UC) and Crohn’s Disease and potentially multiple other immune-mediated diseases.

  • Jnana Therapeutics

    Collaboration to develop small molecules against multiple key regulators of cellular metabolism SLC transporters for selected targets in immunology and neurology.

  • Qyuns

    Global collaboration and license agreement with Qyuns Therapeutics to develop Qyuns’ anti-TSLP:IL33 bi-specific antibody for the treatment of Chronic Obstructive Pulmonary Disease (COPD).

Explore collaboration opportunities

Connect with our partnering experts to start the conversation.

Reach out

More Pharma partnering areas

View all areas
Decorative illustration

Digital and data

Innovation

We are taking PHC toward a future where treatments are targeted to an individual’s needs and unique genetic profile.

Decorative illustration

Infectious Diseases

Innovation

We are advancing innovation to combat infectious diseases like HBV, influenza and MDR.

Decorative illustration

Neurology

Innovation

We focus on advances for neurodegenerative, psychiatric and neurodevelopmental disorders.

Decorative image

Oncology and Haematology

Innovation

We focus on first- and best-in-class therapeutics in molecular targeted therapies and cancer immunotherapy.

Decorative illustration

Ophthalmology

Innovation

We are focusing on saving people’s eyesight from the leading causes of vision loss through pioneering therapies and cutting- edge research.

Decorative illustration

Research Technologies

Innovation

We focus on therapeutic modalities and enabling technologies.

Decorative illustration

Cardiovascular, Renal & Metabolic Disease

Innovation

Roche is committed to making a contribution to areas of huge unmet need and societal burden through transformative science like in cardiovascular and metabolic diseases

Discover more

Infectious diseases

Pharma | Diagnostics

The infectious disease landscape is ever-changing with outbreaks, mutations, emerging pathogens, and growing resistances placing pressures on healthcare systems. Roche is determined to provide relief and care.

Product Development Pipeline

Solutions

Discover our pipeline of Pharmaceutical and Diagnostics developments